The production of quality antibodies is critical to advancing research and treatment options, especially in high-stakes areas like HIV. Recognizing the demand for high-quality single-domain antibodies, ingenious targeting laboratory has taken the first step toward developing a mouse-based platform that meets this need. However, as the antibody